Drugs / NT-KO-003
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01428726 | Jun 2011 → Jan 2014 | relapsing-remitting multiple sclerosis | Neurotec Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NT-KO-003 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01428726 ↗ |
| Route | Oral | “Low Doses of Oral NT-KO-003” NCT01428726 ↗ |